Among the epithelial markers measured, BE samples are characterized by a higher percentage of epithelial cells (CD45-, EpCAM+) including cells expressing Her2, a marker of BE and esophageal adenocarcinoma, and the cell adhesion marker CD49f. The gene discussed is EPCAM; the disease is Barrett esophagus.